[en] Colorectal cancer (CRC) is the third most common cancer diagnosed and the lack of effectiveness of current therapies leads to frequent relapses. Monoclonal antibodies cetuximab and panitumumab are the most used anti-EGFR targeted therapy in CRC. Genetic alterations, such as activating mutations, are commonly associated with a lack of response to anti-EGFR therapy. Strikingly, patients with CRC diagnosed as "quadruple wild type" (unmutated for KRAS, NRAS, BRAF and PIK3CA) also show a lack of response to this therapy.
Reliance of cancer cells on glycolysis promotes tumorigenesis and malignant progression. Methylglyoxal (MG) is an unavoidable glycolytic by-product that glycates proteins, lipids, and DNA. MG stress results from the imbalance between MG production and its enzymatic detoxification by glyoxalase 1 (GLO1). Upon MG stress, cancer cells enhanced their growth and metastatic potential. In our hands, induction of MG stress in quadruple WT cells rendered them resistant to cetuximab. In this project, we aim to explore MG stress-driven molecular mechanisms underlying the acquisition of cetuximab resistance in quadruple WT CRC. Indeed, such resistant tumours could benefit from the targeting of MG stress using potent MG scavengers, such as carnosine and metformin.
We have previously shown that LIM1215 human quadruple WT CRC cells undergo a glycolytic switch associated with MG stress upon the acquisition of cetuximab resistance. GLO1-depleted LIM1215 cells showed an increased viability when challenged with cetuximab. Consistently, NOD-SCID mice sub-cutaneously injected with GLO1-depleted LIM1215 cells developed cetuximab resistant tumours. We aim to use patient-derived xenograft and organoids generated from quadruple WT CRC patients to demonstrate: (1) the occurrence of MG stress and (2) the potential anti-cancer effects of MG scavengers. Mechanistically, we will consider the mutagenic potential of MG on specific oncogenic drivers of CRC, and/or the glycation of specific proteins, such as transcription factors and signalling pathway effectors, known to be implicated in CRC initiation and progression. In summary, this study will highlight the importance of the glycolytic switch in resistance to EGFR targeted therapy in quadruple WT CRC.
Disciplines :
Laboratory medicine & medical technology
Author, co-author :
Lardinois, Fanny ; Université de Liège - ULiège > GIGA ; Université de Liège - ULiège > GIGA > GIGA Cancer - Metastases Research Laboratory
Crake, Rebekah ; Université de Liège - ULiège > GIGA > GIGA Cancer - Metastases Research Laboratory
Bellier, Justine ; Université de Liège - ULiège > GIGA > GIGA Cancer - Metastases Research Laboratory
Vara Messler, Marianela; UCL - Catholic University of Louvain > Institut de recherche expérimentale et clinique > Pole of pharmacology and therapeutics
Richiardone, Elena; UCL - Catholic University of Louvain > Institut de recherche expérimentale et clinique > Pole of pharmacology and therapeutics
Peulen, Olivier ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie dans le domaine des sciences médicales et biomédicales
Corbet, Cyril; UCL - Catholic University of Louvain > Institut de Recherche Expérimentale et Clinique > Pole of pharmacology and therapeutics
Bellahcene, Akeila ; Université de Liège - ULiège > GIGA > GIGA Cancer - Metastases Research Laboratory
Language :
English
Title :
Acquired resistance to EGFR-targeted therapy in quadruple wild-type colorectal cancer: role of methylglyoxal stress
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.